(Q39409543)

English

PKI-587 and sorafenib targeting PI3K/AKT/mTOR and Ras/Raf/MAPK pathways synergistically inhibit HCC cell proliferation

scientific article published on 21 November 2011

Statements

PKI-587 and sorafenib targeting PI3K/AKT/mTOR and Ras/Raf/MAPK pathways synergistically inhibit HCC cell proliferation (English)
Roberto Gedaly
Paul Angulo
Jonathan Hundley
Michael F Daily
Changguo Chen
21 November 2011
542-548

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit